Consonance Capital Management LP / XENE
Consonance Capital Management LP’s Xenon Pharmaceuticals Inc Position
Does Consonance Capital Management LP own Xenon Pharmaceuticals Inc (XENE)? Not currently — the last reported position was 1.98M shares worth $22M in Q1 2020; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$22M
Q1 2020
Shares
1.98M
% of Portfolio
+1.67%
Quarters Held
1
position exited
Position History XENE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2020 | 1.98M | $22M | +1.67% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of XENE.